-
Celldex Therapeutics, Inc. (NASDAQ:CLDX) Given Consensus Recommendation of "Moderate Buy" by Analysts
Source: Buzz FX / 28 Dec 2024 02:37:12 America/New_York
Celldex Therapeutics, Inc. (NASDAQ:CLDX) Given Consensus Recommendation of "Moderate Buy" by Analysts Written by MarketBeat December 28, 2024 Share Link copied to clipboard. Shares of Celldex Therapeutics, Inc.
Read more...